Angiotensin-converting enzymes, ACE and ACE2, are key members of renin angiotensin
system. Activation of ACE2/Ang-(1-7) pathway enhances cardiovascular protective functions …

CD34+ stem/progenitor cells have been identified as a promising cell population for the
autologous cell-based therapies in patients with cardiovascular disease. The counter …

Bone marrow–derived hematopoietic stem/progenitor cells are vasculogenic and play an
important role in endothelial health and vascular homeostasis by participating in postnatal …

Objective—The renin-angiotensin system contributes to atherosclerotic lesion formation.
Angiotensin-converting enzyme 2 (ACE2) catabolizes angiotensin II (Ang II) to angiotensin 1 …

Cardiovascular disease is America's leading health problem and the leading cause of death.
One person in three suffers from some form of cardiovascular disease. There is an urgent …

Angiotensin-converting enzyme 2 (ACE2) is a lately discovered enzyme catalyzing
Angiotensin II into Angiotensin 1-7. Angiotensin II has been reported to impair endothelial …

This study demonstrates that a novel angiotensin I analog, angiotensinogen 3–11 (Lys11),
possesses a high affinity for angiotensin-converting enzyme (ACE), which is substantially …

The dysfunctional nature of CD34+ cells from patients with heart failure (HF) may make them
unsuitable for autologous stem-cell therapy. In view of evidence that the vasoprotective axis …

Abstract Angiotensin-converting enzyme 2 (ACE2) is a recently described member of the
renin-angiotensin system that hydrolyzes angiotensin (Ang) II to Ang-(1-7), and may thereby …

Angiotensin-converting enzyme 2 (ACE2) is a monocarboxypeptidase that metabolizes
several vasoactive peptides, including angiotensin II (Ang-II; a vasoconstrictive/proliferative …